BNP PARIBAS ASSET MANAGEMENT Holding S.A.

Position in XENE — Xenon Pharmaceuticals Inc.

CIK 1520354 Paris, I0

Position in XENE

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$77,908,522

-$130,404 QoQ

Shares Held

1,290,731

-3.8% QoQ

Ownership

1.33%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#22

of 314 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 95% Shared 0% None 5%

Healthcare · as of Jun 30, 2026

BNP PARIBAS ASSET MANAGEMENT Holding S.A. holds $2,249,207,592 across 136 Biotechnology names. XENE ranks #6 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	897,893	$446,010,389
2	REGN	Regeneron Pharmaceuticals, Inc.	331,560	$206,740,921
3	JAZZ	Jazz Pharmaceuticals plc	799,297	$192,606,596
4	ARGX	Argenx SE	121,786	$112,989,396
5	INCY	Incyte Corp	937,763	$106,304,813
6	XENE	Xenon Pharmaceuticals Inc. This page	1,290,731	$77,908,522
7	VCEL	Vericel Corp	1,639,988	$72,963,065
8	CYTK	Cytokinetics Inc	827,810	$70,521,132

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$77,908,522	1,290,731	-3.8%	Shares	Defined	2026-08-13
2026-03-31	$78,038,926	1,342,028	+26.6%	Shares	Defined	2026-05-14
2025-12-31	$47,519,105	1,060,221	+58.2%	Shares	Defined	2026-02-13
2025-09-30	$26,910,817	670,257	+1.4%	Shares	Defined	2025-11-07
2025-06-30	$20,691,866	661,082	-6.1%	Shares	Defined	2025-08-06
2025-03-31	$23,612,322	703,795	+6.0%	Shares	Defined	2025-05-14
2024-12-31	$26,017,196	663,704	+51.2%	Shares	Defined	2025-02-12
2024-09-30	$17,286,342	439,074	+4.3%	Shares	Defined	2024-11-08
2024-06-30	$16,419,507	421,121	+1.1%	Shares	Defined	2024-07-30
2024-03-31	$17,940,484	416,736	—	Shares	Defined	2024-05-08
No filing history on record for this holder in this stock.